Clinical Studies

EMRO is continuously striving to improve on the methods patients are treated. There are a number of areas in which we research and recruit, including:


Actively Enrolling Clinical Studies – Spring 2018


Enrollment Criteria


StandUP #19674
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure (STANDUP AHF)
· Age: ≥18
· History of HF + LVEF ≤40%
· BNP≥400
· SBP 105-160
· No ACS hosp w/i 90 days
Enrollment: M-F 7a-11p
CRC PIC 1044
PI: Chris Ghaemmaghami, MD
VIOLET #19850
Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET)
Enrollment completed. Enrollment: M-F 7a-11p
CRC PIC 1044
PI: Enfield/Sochor
Antares-HF #20333
Alere NT-proBNP for ARCHITECT in an ED Setting for Heart Failure
Enrollment completed. Enrollment: M-F 7a-11p, S-S 1pm-11pm
CRC PIC 1044
PI: Glass
CIREN #20291

Crash Injury Research and Engineering Network Enrolling Center

· Age: Any
· MVC in a newer vehicle
· Severe injuries (1+ AIS ≥3 or 2+ AIS ≥2 injuries)
· Vehicle owner able to consent to be in database
Enrollment: M-F 7a-11p
CRC PIC 1044
PI: Tom Hartka, MD

Upcoming EMRO Studies 

Summer 2018

  • Catalyst TBI Study – Dr. Joshua S. Easter
  • Hemostatic Dressing – Dr. Nathan P. Charlton
  • MATH-VTE – Dr. David R. Burt
  • Alinity Troponin – Doris M. Haverstick, PhD, & Dr. Thomas R. Hartka